Clinical Trial Update: Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating low-dose trimethoprim-sulfamethoxazole for treating Pneumocystis pneumonia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumocystis Pneumonia

Drugs mentioned

• Trimethoprim-sulfamethoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: Todd C. Lee MD MPH FIDSA | Conditions: Pneumocystis, Pneumocystis Pneumonia | Phase 3 | Status: RECRUITING